Video | Agriculture | Confidence | Economy | Energy | Employment | Finance | Media | Property | RBNZ | Science | SOEs | Tax | Technology | Telecoms | Tourism | Transport | Search


Horse Flu Vaccine Application Approved By ERMA

Media Release 21 DECEMBER 2007

Authority Approves Application To Bring In Horse Flu Vaccine

The Environmental Risk Management Authority (ERMA New Zealand) has approved an application by the Ministry of Agriculture and Forestry Biosecurity New Zealand (MAF BNZ) to use a vaccine to protect New Zealand horses against the equine influenza virus.

The equine influenza virus caused major disruption in the horse racing and breeding industry in Australia earlier this year after infected animals were discovered in New South Wales. Thousands of horses eventually tested positive for the virus. Australia has since imported a vaccine to help control the disease.

The use of the Flu Avert I.N vaccine in the event of equine influenza being identified in horses in New Zealand has been approved with a number of conditions placed on its use.

ERMA New Zealand's General Manager, New Organisms, Dr Libby Harrison, says in approving the vaccine the Authority's decision-making committee considered potential adverse effects on public safety and health, valued species, societies and communities, the economy, the environment and natural habitats. "The Committee decided that the risks posed by the vaccine are negligible. However, in recognition of the risks, the committee has imposed conditions on storage, handling and use of the vaccine."

The conditions placed on the vaccine include:

Only approved veterinarians will be able to receive and administer the
Vaccinated horses must be kept separate from unvaccinated horses for a
period of 14 days after vaccination; and
MAF BNZ will keep a register of vaccine importations, approved vets, and
horses that have been vaccinated.

Dr Harrison says the approval of this vaccine gives MAF an additional tool for use in case of an outbreak of equine influenza in New Zealand. The Flu Avert I.N vaccine contains a weakened live equine influenza virus which is administered to horses via the nose. It stimulates an immune response that is similar to the response that occurs when the horse catches a virulent wild strain of the virus. The vaccine still has to be approved by the New Zealand Food Safety Authority's Agricultural Compounds and Veterinary Medicines Group before it can be used.


© Scoop Media

Business Headlines | Sci-Tech Headlines


Voluntary Administration: Renaissance Brewing Up For Sale

Renaissance Brewing, the first local company to raise capital through equity crowdfunding, is up for sale after cash flow woes and product management issues led to the appointment of voluntary administrators. More>>


Approval: Northern Corridor Decision Released

The approval gives the green light to construction of the last link of Auckland’s Western Ring Route, providing an alternative route from South Auckland to the North Shore. More>>


Media Mega Merger: Full Steam Ahead For Appeal

New Zealand's two largest news publishers have confirmed they are committed to pursuing their appeal against the Commerce Commission's rejection of the proposal to merge their operations. More>>

Crown Accounts: $4.1 Billion Surplus

The New Zealand Government has achieved its third fiscal surplus in a row with the Crown accounts for the year ended 30 June 2017 showing an OBEGAL surplus of $4.1 billion, $2.2 billion stronger than last year, Finance Minister Steven Joyce says. More>>


Mycoplasma Bovis: One New Property Tests Positive

The newly identified property... was already under a Restricted Place notice under the Biosecurity Act. More>>

Accounting Scandal: Suspension Of Fuji Xerox From All-Of-Government Contract

General Manager of New Zealand Government Procurement John Ivil says, “FXNZ has been formally suspended from the Print Technology and Associated Services (PTAS) contract and terminated from the Office Supplies contract.” More>>